Research Overview
Published studies and early-stage research have discussed Retatrutide in connection with:
• Multi-receptor agonism involving GLP-1, GIP, and glucagon pathways
• Energy expenditure and metabolic rate modulation
• Glucose control and insulin sensitivity
• Body composition changes under controlled experimental conditions
The current evidence base includes preclinical and early human clinical research, with ongoing studies expanding understanding of its effects.